Skip to main content
. 2018 Nov 14;119(11):1367–1373. doi: 10.1038/s41416-018-0285-5

Fig. 3.

Fig. 3

Disease-free survival curves for the combined cohort. Blue represents CDX2-positive, yellow CDX2-moderate with preserved expression of CDX2 in the budding cells, red CDX2-moderate with lost expression of CDX2 in the budding cells and grey CDX2-negative tumours